ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

Supplements Reduce Deaths In NCI Studies In China “JNCI”

September 17, 1993

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

April 11, 1986

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

HHS News: Skin Cancer Awareness Initiative Begun

May 29, 1998

Funding Opportunities

January 24, 2003